Trial intelligence / Profile preview

BaiRui Granules for Pediatric Acute Upper Respiratory Tract Infection (Wind-Heat Pattern)

CTR20241591Phase 3Completed

Sponsor
Jiuhua Huayuan Pharmaceutical
Start
May 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Bairui granules in upper respiratory infection (URI), sponsored by Jiuhua Huayuan Pharmaceutical. Started May 2024; status: completed.

02

Drugs

Bairui granules
03

Conditions

upper respiratory infection (URI)

Beyond the preview

Go deeper on CTR20241591.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20241591.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call